Lifordi Focuses on Autoimmune Diseases

Biotech companies are using antibodies to precisely target drugs in the body

- BY BRIAN GORMLEY

Startup Lifordi Immunotherapeutics aims to bring a potent class of cancer treatments to patients with autoimmune diseases, the fruit of decades of research into combining antibodies and drugs.